MedTrace Logo

US National OCS Liver Perfusion (OLP) Registry

NCT05940857 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-08-16

No results posted yet for this study

Summary

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight.

TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Conditions

  • Liver Transplant

Interventions

DEVICE

OCS Liver

The TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Principal Investigators

  • Ahmed Elbetanony, MD · TransMedics

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-14
Primary Completion
2031-10-31
Completion
2031-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940857 on ClinicalTrials.gov